Hypercholesterolemia-induced impairment in sorafenib functionality is overcome by avasimibe co-treatment
Dipti Athavale, Himanshi Yaduvanshi, Firoz Khan Bhati, Shyamananda Singh Mayengbam, Tushar H. More, Srikanth Rapole, Manoj Kumar Bhat
This study shows that avasimibe restores sorafenib's anticancer effect in hypercholesterolemia-induced hepatocellular carcinoma by enhancing cytotoxicity and reducing ERK signaling.
Journal of Biosciences · May 15, 2026Peer-reviewedCancer Biology